Literature DB >> 24565508

Long-term diabetic response to gastric bypass.

Stephen W Davies1, Jimmy T Efird2, Christopher A Guidry3, Rachel I Penn4, Robert G Sawyer3, Bruce D Schirmer3, Peter T Hallowell3.   

Abstract

BACKGROUND: As obesity and type II diabetes continue to rise, bariatric surgery offers a solution, but few long-term studies are available. The purpose of this study was to evaluate the long-term outcomes of diabetic patients after gastric bypass.
MATERIALS AND METHODS: This was a retrospective cohort study of all diabetic patients undergoing gastric bypass at our institution, from 1998 to 2012. Patients were compared by postoperative diabetic response to treatment (i.e., response = off oral medication/insulin versus refractory = on oral medication/insulin) and followed at 1-, 3-, 5-, and 10-y intervals. Continuous data were analyzed using Student t-test or Wilcoxon rank-sum test. Multivariable, Cox proportional hazard regression model was performed to compute diabetic cure ratios and 95% confidence intervals.
RESULTS: A total of 2454 bariatric surgeries were performed at our institution during the time period. A total of 707 diabetic patients were selected by Current Procedural Terminology codes for gastric bypass. Mean follow-up was 2.1 y. Incidence of diabetic response was 56% (1 y), 58% (3 y), 60% (5 y), and 44% (10 y). Postoperatively, responsive patients experienced greater percentage of total body weight loss (1 y [P < 0.0001], 3 y [P = 0.0087], and 5 y [P = 0.013]), and less hemoglobin A1c levels (1 y [P = 0.035] and 3 y [P = 0.040]) at follow-up than refractory patients. Multivariable analysis revealed a significant, independent inverse trend in incidence of diabetic cure as both age and body mass index decreased (Ptrend = 0.0019 and <0.0001, respectively). In addition, degenerative joint disease was independently associated with responsive diabetes (cure ratio = 1.6 [95% confidence interval = 1.1-2.2]).
CONCLUSIONS: At follow-up, both groups in our study experienced substantial weight loss; however, a greater loss was observed among the response group. Further research is needed to evaluate methods for optimizing patient care preoperatively and improving patient follow-up.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes; Diabetes cure; Gastric bypass; Long-term follow-up

Mesh:

Year:  2014        PMID: 24565508      PMCID: PMC4096603          DOI: 10.1016/j.jss.2014.01.047

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  34 in total

1.  Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.

Authors:  N B Jørgensen; S H Jacobsen; C Dirksen; K N Bojsen-Møller; L Naver; L Hvolris; T R Clausen; B S Wulff; D Worm; D Lindqvist Hansen; S Madsbad; J J Holst
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-04-24       Impact factor: 4.310

2.  Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity.

Authors:  Tom C Hall; Mike G C Pellen; Peter C Sedman; Prashant K Jain
Journal:  Obes Surg       Date:  2010-09       Impact factor: 4.129

3.  Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass.

Authors:  Numan Hamza; Muhammad Hasan Abbas; Ammar Darwish; Zainab Shafeek; John New; Basil J Ammori
Journal:  Surg Obes Relat Dis       Date:  2010-04-07       Impact factor: 4.734

4.  A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass.

Authors:  David E Arterburn; Andy Bogart; Nancy E Sherwood; Stephen Sidney; Karen J Coleman; Sebastien Haneuse; Patrick J O'Connor; Mary Kay Theis; Guilherme M Campos; David McCulloch; Joe Selby
Journal:  Obes Surg       Date:  2013-01       Impact factor: 4.129

5.  Health benefits of gastric bypass surgery after 6 years.

Authors:  Ted D Adams; Lance E Davidson; Sheldon E Litwin; Ronette L Kolotkin; Michael J LaMonte; Robert C Pendleton; Michael B Strong; Russell Vinik; Nathan A Wanner; Paul N Hopkins; Richard E Gress; James M Walker; Tom V Cloward; R Tom Nuttall; Ahmad Hammoud; Jessica L J Greenwood; Ross D Crosby; Rodrick McKinlay; Steven C Simper; Sherman C Smith; Steven C Hunt
Journal:  JAMA       Date:  2012-09-19       Impact factor: 56.272

6.  Is type II diabetes mellitus (NIDDM) a surgical disease?

Authors:  W J Pories; K G MacDonald; E G Flickinger; G L Dohm; M K Sinha; H A Barakat; H J May; P Khazanie; M S Swanson; E Morgan
Journal:  Ann Surg       Date:  1992-06       Impact factor: 12.969

7.  Long-term results 11 years after primary gastric bypass in 384 patients.

Authors:  David Edholm; Felicity Svensson; Ingmar Näslund; F Anders Karlsson; Eva Rask; Magnus Sundbom
Journal:  Surg Obes Relat Dis       Date:  2012-03-23       Impact factor: 4.734

8.  Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study.

Authors:  Kusal Wickremesekera; Geoff Miller; Tissa Desilva Naotunne; Graham Knowles; Richard S Stubbs
Journal:  Obes Surg       Date:  2005-04       Impact factor: 4.129

9.  GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects.

Authors:  Amanda Jiménez; Roser Casamitjana; Lílliam Flores; Salvadora Delgado; Antonio Lacy; Josep Vidal
Journal:  Ann Surg       Date:  2013-05       Impact factor: 12.969

10.  Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity.

Authors:  Ricardo V Cohen; Jose C Pinheiro; Carlos A Schiavon; João E Salles; Bernardo L Wajchenberg; David E Cummings
Journal:  Diabetes Care       Date:  2012-07       Impact factor: 19.112

View more
  6 in total

1.  The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass.

Authors:  Judith Aron-Wisnewsky; Nataliya Sokolovska; Yuejun Liu; Doron S Comaneshter; Shlomo Vinker; Tal Pecht; Christine Poitou; Jean-Michel Oppert; Jean-Luc Bouillot; Laurent Genser; Dror Dicker; Jean-Daniel Zucker; Assaf Rudich; Karine Clément
Journal:  Diabetologia       Date:  2017-07-21       Impact factor: 10.122

2.  Type 2 Diabetes Remission After Gastric Bypass: What Is the Best Prediction Tool for Clinicians?

Authors:  Aurélie Cotillard; Christine Poitou; Guillemette Duchâteau-Nguyen; Judith Aron-Wisnewsky; Jean-Luc Bouillot; Thomas Schindler; Karine Clément
Journal:  Obes Surg       Date:  2015-07       Impact factor: 4.129

3.  Vancomycin-Associated Nephrotoxicity: The Obesity Factor.

Authors:  Stephen W Davies; Jimmy T Efird; Christopher A Guidry; Zachary C Dietch; Rhett N Willis; Puja M Shah; Sara A Hennessy; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2015-09-01       Impact factor: 2.150

4.  Twenty-first century weight loss: banding versus bypass.

Authors:  Stephen W Davies; Jimmy T Efird; Christopher A Guidry; Rachel I Penn; Robert G Sawyer; Bruce D Schirmer; Peter T Hallowell
Journal:  Surg Endosc       Date:  2014-08-09       Impact factor: 4.584

5.  Should Roux-en-Y gastric bypass biliopancreatic limb length be tailored to achieve improved diabetes outcomes?

Authors:  Mário Nora; Tiago Morais; Rui Almeida; Marta Guimarães; Mariana P Monteiro
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

6.  Increase of the Adiponectin/Leptin Ratio in Patients with Obesity and Type 2 Diabetes after Roux-en-Y Gastric Bypass.

Authors:  Xabier Unamuno; Maitane Izaguirre; Javier Gómez-Ambrosi; Amaia Rodríguez; Beatriz Ramírez; Sara Becerril; Víctor Valentí; Rafael Moncada; Camilo Silva; Javier Salvador; Piero Portincasa; Gema Frühbeck; Victoria Catalán
Journal:  Nutrients       Date:  2019-09-03       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.